Conquering Diseases

Study Of An Investigational Drug For Non-Relapsing Secondary Progressive Multiple Sclerosis


Seeking men and women aged 18-60 for a study of an investigational drug for non-relapsing secondary progressive multiple sclerosis.


Participants in this study will be randomly assigned to get either the investigational drug or a placebo (looks like the drug but contains no medicine). Participants are twice as likely to get the investigational drug than the placebo.

What we're hoping for

We are studying whether an investigational drug taken as a tablet by mouth daily is safe and effective in preventing brain lesions for people with non-relapsing secondary progressive multiple sclerosis .

Additional Information Identifier: NCT04411641

 Principal Investigator

Roberto  Bomprezzi, MD, PhD

UMass Memorial Health Care

 Study Contact

Meaghan  Demers-Peel


UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655